Page last updated: 2024-08-25

isaxonine and triiodothyronine

isaxonine has been researched along with triiodothyronine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bijlsma, WA; Gispen, WH; Jennekens, FG; Schotman, P1

Reviews

2 review(s) available for isaxonine and triiodothyronine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Neurotrophic factors and regeneration in the peripheral nervous system.
    Psychoneuroendocrinology, 1984, Volume: 9, Issue:3

    Topics: Adrenocorticotropic Hormone; Animals; Cyclic AMP; Cyclophosphamide; Gangliosides; Goldfish; Nerve Degeneration; Nerve Growth Factors; Nerve Regeneration; Peripheral Nerves; Polyamines; Pyrimidines; Rats; Testosterone; Thyroxine; Triiodothyronine; Vitamin B Complex

1984

Other Studies

1 other study(ies) available for isaxonine and triiodothyronine

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011